Articles

Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T cell responses in a murine acute myeloid leukemia model

Beth Israel Deaconess Medical Center, Harvard Medical School
Beth Israel Deaconess Medical Center, Harvard Medical School
Beth Israel Deaconess Medical Center, Harvard Medical School
Beth Israel Deaconess Medical Center, Harvard Medical School
Beth Israel Deaconess Medical Center, Harvard Medical School
Beth Israel Deaconess Medical Center, Harvard Medical School
Beth Israel Deaconess Medical Center, Harvard Medical School
Beth Israel Deaconess Medical Center, Harvard Medical School
Beth Israel Deaconess Medical Center, Harvard Medical School
Beth Israel Deaconess Medical Center, Harvard Medical School
Beth Israel Deaconess Medical Center, Harvard Medical School
Beth Israel Deaconess Medical Center, Harvard Medical School
Beth Israel Deaconess Medical Center, Harvard Medical School
Beth Israel Deaconess Medical Center, Harvard Medical School
Beth Israel Deaconess Medical Center, Harvard Medical School
Beth Israel Deaconess Medical Center, Harvard Medical School
Beth Israel Deaconess Medical Center, Harvard Medical School
Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School
Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School
Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School
Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School
Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School
Beth Israel Deaconess Medical Center, Harvard Medical School
Beth Israel Deaconess Medical Center, Harvard Medical School
Haematologica Early view Feb 4, 2021 https://doi.org/10.3324/haematol.2020.259457